Azathioprine/leflunomide/rituximabCOVID-19: 3 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1971卷 / 1期

关键词：

D O I：

10.1007/s40278-023-45177-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：52 / 52

相关论文

共 50 条

[21] RituximabCOVID-19: case report [J].

Reactions Weekly, 2022, 1901 (1) :418-418

[22] RituximabCOVID-19 infection: case report [J].

Reactions Weekly, 2024, 2023 (1) :360-360

[23] RituximabCOVID-19 [J].

Reactions Weekly, 2024, 2010 (1) :351-351

[24] RituximabCOVID-19 infection: case report [J].

Reactions Weekly, 2021, 1878 (1) :463-463

[25] RituximabCOVID-19 pneumonia: case report [J].

Reactions Weekly, 2025, 2040 (1) :869-869

[26] RituximabCOVID-19 infection: case report [J].

Reactions Weekly, 2021, 1857 (1) :304-304

[27] RituximabCOVID-19 infection : case report [J].

Reactions Weekly, 2024, 2018 (1) :409-409

[28] RituximabCOVID-19 infection: case report [J].

Reactions Weekly, 2022, 1909 (1) :486-486

[29] Prednisone/rituximabCOVID-19: case report [J].

Reactions Weekly, 2021, 1865 (1) :367-367

[30] RituximabCOVID-19 pneumonia: case report [J].

Reactions Weekly, 2024, 2021 (1) :472-472

← 1 2 3 4 5 →